Kang et al. reported on the dual-utilization OncoBean (DUO) by targeting separation of EVs using melanoma-specific antibodies melanoma cell adhesion molecule (MCAM) and melanoma-associated chondroitin sulfate proteoglycan (MCSP) [92]. Here, CSPG4 is linked to melanoma.